Insider · CIK 0001764572
Ann Michelle Cunningham
Files at VTGN (Vistagen Therapeutics, Inc.). First filing -, latest -.
Ann Michelle Cunningham files SEC Form 4 as director at VTGN (Vistagen Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ann Michelle Cunningham has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +17,600 | $0.00 | $0 | 17,600 | Sep 11, 2025 |
Questions about Ann Michelle Cunningham
Answered from the filings on this page, as of the latest one.
Is Ann Michelle Cunningham buying or selling?
Ann Michelle Cunningham has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ann Michelle Cunningham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ann Michelle Cunningham has 0.
Where does Ann Michelle Cunningham file Form 4?
Ann Michelle Cunningham has filed Form 4 at VTGN (Vistagen Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.